DK0972521T3 - Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer - Google Patents

Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer

Info

Publication number
DK0972521T3
DK0972521T3 DK99202497T DK99202497T DK0972521T3 DK 0972521 T3 DK0972521 T3 DK 0972521T3 DK 99202497 T DK99202497 T DK 99202497T DK 99202497 T DK99202497 T DK 99202497T DK 0972521 T3 DK0972521 T3 DK 0972521T3
Authority
DK
Denmark
Prior art keywords
stimulators
gamma
pharmaceutical preparation
preparation containing
containing interferon
Prior art date
Application number
DK99202497T
Other languages
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DK0972521T3 publication Critical patent/DK0972521T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK99202497T 1995-08-18 1996-08-09 Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer DK0972521T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9516967A GB2304342A (en) 1995-08-18 1995-08-18 Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma

Publications (1)

Publication Number Publication Date
DK0972521T3 true DK0972521T3 (da) 2003-05-05

Family

ID=10779448

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99202497T DK0972521T3 (da) 1995-08-18 1996-08-09 Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer
DK96927141T DK0845007T3 (da) 1995-08-18 1996-08-09 Farmaceutisk præparat indeholdende interferon-gamma hæmmere

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK96927141T DK0845007T3 (da) 1995-08-18 1996-08-09 Farmaceutisk præparat indeholdende interferon-gamma hæmmere

Country Status (13)

Country Link
EP (2) EP0845007B1 (da)
JP (2) JP4070809B2 (da)
AT (2) ATE231728T1 (da)
AU (1) AU713809B2 (da)
CA (1) CA2229590C (da)
DE (2) DE69626050T2 (da)
DK (2) DK0972521T3 (da)
ES (2) ES2192018T3 (da)
GB (1) GB2304342A (da)
HK (1) HK1023516A1 (da)
PT (2) PT972521E (da)
WO (1) WO1997007136A2 (da)
ZA (1) ZA966953B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ES2251248T3 (es) 1998-12-09 2006-04-16 Protein Design Labs, Inc. Uso de anticuerpos contra il-12 para tratar la psoriasis.
US6710025B1 (en) 1999-05-26 2004-03-23 The Brigham And Women's Hospital, Inc. Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
JP2003500113A (ja) * 1999-05-26 2003-01-07 ザ ブリガム アンド ウイミンズ ホスピタル、 インコーポレイテッド アルファ平滑筋アクチン活性を調節する薬剤の治療的使用
US10080779B2 (en) 2004-12-15 2018-09-25 Universite D'angers Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM
JP5530635B2 (ja) * 2007-02-14 2014-06-25 独立行政法人科学技術振興機構 腸管癒着抑制剤
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
RU2539383C1 (ru) * 2013-11-29 2015-01-20 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Фармацевтическая композиция для лечения трофических язв и длительно незаживающих ран различной этиологии в виде мази

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
NL8700927A (nl) * 1987-04-16 1988-11-16 Stichting Rega V Z W Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
CA1335792C (en) * 1987-08-18 1995-06-06 Chaim O. Jacob Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
SG43205A1 (en) * 1988-12-19 1997-10-17 American Cyanamid Co A method for the treatment of endotoxic shock in a mammal
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
ATE132191T1 (de) * 1989-04-19 1996-01-15 Hoffmann La Roche Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung
IT1231727B (it) * 1989-08-11 1991-12-21 Enrico Savoldi Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
ZA917669B (en) * 1990-09-27 1992-08-26 Schering Corp Antagonists of human gamma interferon
WO1992014480A1 (en) * 1991-02-22 1992-09-03 Amgen Inc. Use of gm-csf and g-csf to promote accelerated wound healing
NL9101290A (nl) * 1991-07-23 1993-02-16 Stichting Rega V Z W Recombinant dna-molecuul voor de expressie van een fv-fragment van een antilichaam.
DE4234380A1 (de) * 1992-10-06 1994-04-07 Schering Ag Verwendung von Dopaminagonisten zur Aktivierung des gamma-Interferon-Produktion
JPH07508763A (ja) * 1992-11-20 1995-09-28 シェリング・コーポレーション ヒトγインターフェロンのアンタゴニスト
ES2126094T3 (es) * 1992-12-29 1999-03-16 Genentech Inc Tratamiento de la enfermedad inflamatoria de los intestinos con inhibidores del interferon-gamma.
CA2177471A1 (en) * 1993-12-09 1995-06-15 Michel Aguet Ifn-.gamma.receptor .beta.-chain and derivatives thereof

Also Published As

Publication number Publication date
AU6707196A (en) 1997-03-12
EP0972521B1 (en) 2003-01-29
EP0972521A1 (en) 2000-01-19
JP4616291B2 (ja) 2011-01-19
AU713809B2 (en) 1999-12-09
CA2229590C (en) 2010-10-12
DE69626050T2 (de) 2004-01-22
ATE231728T1 (de) 2003-02-15
EP0845007A2 (en) 1998-06-03
ZA966953B (en) 1998-02-16
CA2229590A1 (en) 1997-02-27
ES2192018T3 (es) 2003-09-16
PT845007E (pt) 2002-03-28
PT972521E (pt) 2003-06-30
DE69626050D1 (de) 2003-03-06
DK0845007T3 (da) 2001-12-17
ATE208402T1 (de) 2001-11-15
HK1023516A1 (en) 2000-09-15
WO1997007136A3 (en) 1997-08-21
EP0845007B1 (en) 2001-11-07
GB2304342A (en) 1997-03-19
GB9516967D0 (en) 1995-10-18
WO1997007136A2 (en) 1997-02-27
JP4070809B2 (ja) 2008-04-02
JPH11511160A (ja) 1999-09-28
JP2007119497A (ja) 2007-05-17
DE69616803D1 (de) 2001-12-13
DE69616803T2 (de) 2002-06-20
ES2164911T3 (es) 2002-03-01

Similar Documents

Publication Publication Date Title
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
SE9704546D0 (sv) Novel compounds
AP1697A (en) Azabicycloalkanes as CCR5 modulators.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DK1200412T3 (da) Antiproliferative imidazolforbindelser
ATE231872T1 (de) Thiazolopyrimidinderivate
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
DK0499923T3 (da) Dentaladhæsiv
FI955136A (fi) Gamma-interferonin stabiilit, nestemäiset koostumukset
IT8467840A1 (it) Composto e composizione farmaceutica per il trattamento della osteoporosi.
DK0972521T3 (da) Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
ES2195000T3 (es) Composicion farmaceutica.
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DK116386D0 (da) Polyprenylforbindelser, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
IT1292017B1 (it) Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso
IT8219652A0 (it) Derivato della propionilglicina, processi per la sua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
SE9803277D0 (sv) Novel compounds
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.